Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,241,708
in 3 filings, $108K under 10b5-1 plans

Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-06 Rothman Paul Director Option exercise +717 717
2024-06-06 Rothman Paul Director Option exercise · Restricted Stock Unit −717 944
2024-05-14 van der Vaart Sandra D EVP, Chief Legal Officer Sale −1,800 $210.83 $379K 5,836.98
2024-05-14 van der Vaart Sandra D EVP, Chief Legal Officer Sale −200 $210.84 $42K 5,636.98
2024-05-02 ANDERSON KERRII B Director Sale −250 $200.10 $50K 15,722
2024-04-30 ANDERSON KERRII B Director Sale −250 $204.14 $51K 15,972
2024-04-30 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise +10,229 50,785
2024-04-30 EISENBERG GLENN A Chief Financial Officer, EVP Shares withheld for taxes −4,496 $201.37 $905K 46,289
2024-04-30 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise · Performance Share Unit −10,229 0
2024-04-29 Wilkinson Peter J SVP, Chief Accounting Officer Sale −2,439 $204.33 $498K 2,087.22
2024-04-15 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise +10,229 45,052
2024-04-15 EISENBERG GLENN A Chief Financial Officer, EVP Shares withheld for taxes −4,496 $203.32 $914K 40,556
2024-04-15 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise · Restricted Stock Unit −10,229 5,477
2024-04-01 Schroeder Mark S EVP, Pres Diagnostics & COO Sale 10b5-1 −6,477 $217.29 $1.4M 5,036.14
2024-04-01 Summy Amy B. EVP, Chief Marketing Officer Sale 10b5-1 −3,500 $217.29 $761K 3,975
2024-04-01 Bailey Megan D. EVP, Chief Strategy Officer Option exercise +205 505
2024-04-01 Bailey Megan D. EVP, Chief Strategy Officer Shares withheld for taxes −69 $216.35 $15K 436
2024-04-01 Bailey Megan D. EVP, Chief Strategy Officer Option exercise · Restricted Stock Unit −205 5,407
2024-03-28 van der Vaart Sandra D EVP, Chief Legal Officer Sale 10b5-1 −3,553 $216.74 $770K 7,636.98
2024-03-27 van der Vaart Sandra D EVP, Chief Legal Officer Option exercise 10b5-1 +6,158 13,794.98

Page 25 of 28 · 545 trades